Evidence map›Paper›PMID 30602518›Full record

ArticleAntimicrobial agents and chemotherapy2019

A Rapid Unraveling of the Activity and Antibiotic Susceptibility of Mycobacteria.

A Mustazzolu, L Venturelli, S Dinarelli, K Brown, R A Floto, G Dietler, L Fattorini, S Kasas, M Girasole, G Longo

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Rapid delineation ofMicrobiology spectrum · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Real-time evaluation of macozinone activity againstAntimicrobial agents and chemotherapy · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Simple optical nanomotion method for single-bacterium viability and antibiotic response testing.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

A Mustazzolu *Istituto Superiore di Sanità, Rome, Italy.
L Venturelli *LPMV-IPHYS, Ecole Polytechnique Fédérale Lausanne, Lausanne, Switzerland.
S DinarelliIstituto di Struttura della Materia, Consiglio Nazionale delle Ricerche, Rome, Italy.
K BrownMolecular Immunity Unit, University of Cambridge, Cambridge, United Kingdom.
R A FlotoMolecular Immunity Unit, University of Cambridge, Cambridge, United Kingdom.
G DietlerLPMV-IPHYS, Ecole Polytechnique Fédérale Lausanne, Lausanne, Switzerland.
L FattoriniIstituto Superiore di Sanità, Rome, Italy.
S KasasLPMV-IPHYS, Ecole Polytechnique Fédérale Lausanne, Lausanne, Switzerland.
M GirasoleIstituto di Struttura della Materia, Consiglio Nazionale delle Ricerche, Rome, Italy.
G LongoIstituto di Struttura della Materia, Consiglio Nazionale delle Ricerche, Rome, Italy longo@ism.cnr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of antibiotic-resistant bacteria is a worldwide health-related emergency that calls for new tools to study the bacterial metabolism and to obtain fast diagnoses. Indeed, the conventional analysis time scale is too long and affects our ability to fight infections. Slowly growing bacteria represent a bigger challenge, since their analysis may require up to months. Among these bacteria,

Indexed as

Antibiotics, AntitubercularHumansMicrobial Sensitivity TestsMycobacterium abscessusMycobacterium bovisMycobacterium Infections, NontuberculousMycobacterium tuberculosisTuberculosis, PulmonaryAntibiotics, Antitubercularantibiotic responsecollective movementsfast characterizationmetabolic activitymycobacteriananomotion sensorsusceptibility

Identifiers

PMID30602518
PMCPMC6395931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.